These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Heparin complex formation with plasma fibrin-stabilizing factor in vitro]. Ul'ianov AM; Kudriashov BA; Liapina LA Biokhimiia; 1973; 38(6):1281-7. PubMed ID: 4802010 [No Abstract] [Full Text] [Related]
4. [Reaction between heparin and fibrin monomer and fibrin monomer--fibrinogen complexes]. Kudriashov BA; Liapina LA; Grigorova EA Vopr Med Khim; 1980; 26(3):318-21. PubMed ID: 7456362 [No Abstract] [Full Text] [Related]
5. [Electron microscopic study of the products from dissolving unstabilized fibrin with complex heparin compounds]. Ul'ianov AM; Zhitnikova ES Biokhimiia; 1978; 43(4):646-52. PubMed ID: 656495 [TBL] [Abstract][Full Text] [Related]
6. [Factor XIII-heparin complex and its properties as a physiological solvent for unstabilized fibrin]. Ul'ianov AM; Kudriashov BA Vopr Med Khim; 1975; 21(1):19-23. PubMed ID: 235172 [TBL] [Abstract][Full Text] [Related]
7. Formation of complexes of heparin with proteins and its physiological role. II. Lyapina LA; Ul'yanov AM Hum Physiol; 1979; 4(2):239-48. PubMed ID: 156146 [No Abstract] [Full Text] [Related]
8. [The effect of heparin on fibrin clot stabilization]. Rustamova BA; Molchanova LV; Kudriashov BA Vopr Med Khim; 1970; 16(3):290-3. PubMed ID: 4247924 [No Abstract] [Full Text] [Related]
9. [Complexes of heparin with antiplasmins and several of their properties]. Pastorova VE; Kudrashov BA; Rodina VI Vopr Med Khim; 1973; 19(5):492-7. PubMed ID: 4788172 [No Abstract] [Full Text] [Related]
10. [Formation of a secondary adrenaline-heparin-fibrinogen complex and its properties]. Kudriashov BA; Liapina LA; Zhitnikova ES; Obraztsov VV Vopr Med Khim; 1975; 21(1):65-9. PubMed ID: 1119113 [TBL] [Abstract][Full Text] [Related]
12. [The effect of plasmin from cadaveric plasma on fibrinogen and fibrin]. Levin GIa Prikl Biokhim Mikrobiol; 1974; 10(5):688-90. PubMed ID: 4282509 [No Abstract] [Full Text] [Related]
13. [Factor XIII, its physiological significance (a review of the literature)]. Baluda VP; Zhukova NA Probl Gematol Pereliv Krovi; 1973 Feb; 18(2):34-40. PubMed ID: 4271843 [No Abstract] [Full Text] [Related]
14. Comparative effects of proteinase inhibitors, plasminogen antiactivators, heparin and acetylsalicylic acid on the experimental disseminated intravascular coagulation induced by thormbin. Moriau M; Rodhain J; Noel H; Beys-Col CD; Masure R Thromb Diath Haemorrh; 1974 Sep; 32(1):171-88. PubMed ID: 4281540 [TBL] [Abstract][Full Text] [Related]
15. A review of the basic mechanisms of fibrinogen to fibrin conversion and of fibrinolysis: intravascular coagulation versus primary fibrinolysis. Colick JA; Fisher LM Va Med Mon (1918); 1970 May; 97(5):310-4 passimass. PubMed ID: 4276992 [No Abstract] [Full Text] [Related]
16. New method to prepare autologous fibrin glue on demand. Alston SM; Solen KA; Broderick AH; Sukavaneshvar S; Mohammad SF Transl Res; 2007 Apr; 149(4):187-95. PubMed ID: 17383592 [TBL] [Abstract][Full Text] [Related]
17. [Comparative study of the properties of a fibrinogen--heparin complex produced in vitro and one isolated from a plasma fraction of fibrinogen degradation products]. Kudriashov BA; Liapina LA; Zhitnikova ES; Kriukova MG Nauchnye Doki Vyss Shkoly Biol Nauki; 1979; (9):58-62. PubMed ID: 497299 [No Abstract] [Full Text] [Related]
18. [Modern data on the chemistry and physiology of fibrinogen]. Andreenko GV Usp Sovrem Biol; 1974; 77(1):51-69. PubMed ID: 4282801 [No Abstract] [Full Text] [Related]